VEGF and angiogenesis: implications for breast cancer therapy
Author:
- Joachim DrevsJDJoachim Drevs
- 1 March 2008
- journal article
- review article
- Published by Elsevier in European Journal of Cancer Supplements
- Vol. 6 (6) , 7-13
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Molecular regulation of vessel maturationNature Medicine, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Vascular Endothelial Growth Factor Modulates the Transendothelial Migration of MDA-MB-231 Breast Cancer Cells through Regulation of Brain Microvascular Endothelial Cell PermeabilityJournal of Biological Chemistry, 2003
- Role of angiogenesis in tumor growth and metastasisSeminars in Oncology, 2002
- Clinical Implications of Circulating Angiogenic Factors in Cancer PatientsJournal of Clinical Oncology, 2001
- Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction PathwayJournal of Biological Chemistry, 1998
- Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial CellsJournal of Biological Chemistry, 1998
- Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawalProceedings of the National Academy of Sciences, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971